VivoSim Labs (VIVS) Cash from Operations (2010 - 2026)
VivoSim Labs (VIVS) posted Cash from Operations of -$3.2 million for Q2 2026, down 44.27% on a QoQ basis from -$2.2 million in Q1 2026, and up 18.45% year-over-year from -$2.7 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Cash from Operations (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Cash from Operations for 17 years, with the latest figure at -$3.2 million in Q2 2026.
- On a quarterly basis, Cash from Operations rose 18.45% year-over-year to -$3.2 million in Q2 2026; TTM through Jun 2026 was -$10.1 million, a 3.05% increase from a year earlier, with the FY2026 full-year figure at -$10.8 million, down 14.44% from the prior year.
- Cash from Operations was -$3.2 million for Q2 2026 at VivoSim Labs, down from -$2.2 million in the prior quarter.
- The five-year high for Cash from Operations was -$1.5 million in Q1 2022, with the low at -$5.3 million in Q2 2023.
- Average Cash from Operations over 5 years is -$2.9 million, with a median of -$2.7 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 207.14% in 2023, then jumped 48.86% in 2024.
- Over 5 years, Cash from Operations stood at -$3.0 million in 2022, then decreased by 15.7% to -$3.5 million in 2023, then surged by 48.86% to -$1.8 million in 2024, then declined by 26.71% to -$2.3 million in 2025, then plunged by 40.8% to -$3.2 million in 2026.
- The last three Cash from Operations figures came in at -$3.2 million (Q2 2026), -$2.2 million (Q1 2026), and -$2.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 162.01 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 281.27 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 179.73 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 28.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -44.27 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -492,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.21 Mn |
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -1.80 Mn |
| Sep 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Mar 31, 2024 | -2.67 Mn |
| Dec 31, 2023 | -3.52 Mn |
| Sep 30, 2023 | -3.15 Mn |
| Jun 30, 2023 | -5.31 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | -3.04 Mn |
| Sep 30, 2022 | -2.22 Mn |
| Jun 30, 2022 | -2.41 Mn |
| Mar 31, 2022 | -1.54 Mn |
| Dec 31, 2021 | -3.36 Mn |
| Sep 30, 2021 | -2.14 Mn |